Please assess the completion status of the following clinical trial:

Trial Title: Non-invasive Vagus Nerve Stimulation (nVNS) in Pediatric Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion criteria:~* Diagnosis of CIDP based upon clinical/electrophysiological criteria~* On treatment for CIDP including IVIG and/ or steroids/plasma exchange~Exclusion criteria:~* Inherited polyneuropathy, such as Charcot Tooth Marie disease~* Abnormal baseline EKG, heart disease, epilepsy, pregnancy, multiple sclerosis and diabetes mellitus

- Gender: ALL
- Minimum Age: 5 Years
- Maximum Age: 21 Years
- Healthy Volunteers: f

Study Arms:
- Non-invasive vagus nerve stimulation (nVNS) (Type: EXPERIMENTAL): Participants will use the electrical neuromuscular stimulator device, VitalStim 400, which has been used in previous clinical studies for modulation of pain and has received FDA approval. Participants will also continue to take their standard of care medication.

Based on this trial design, predict the completion outcome and termination type (if applicable).